JAMES VIOLANTE: Open Payments
NPI 1235637547 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$890 in 42 payments from 16 companies in 2025. Trend: 2023 $432 · 2024 $1,930 · 2025 $890
Food & beverage: $890
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $191 |
| GlaxoSmithKline, LLC. | 5 | $125 |
| Exact Sciences Corporation | 5 | $85 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $81 |
| ABBVIE INC. | 3 | $71 |
| AstraZeneca Pharmaceuticals LP | 4 | $62 |
| Astellas Pharma US Inc | 2 | $42 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $38 |
| Esperion Therapeutics, Inc. | 2 | $35 |
| Novartis Pharmaceuticals Corporation | 1 | $31 |
Products named: TRELEGY ELLIPTA, Wegovy, The Cologuard Plus Collection Kit, Ozempic, FARXIGA, JARDIANCE, VRAYLAR, Veozah.
Industry payments across FL — which companies pay providers there.
